Differentiation of H. pylori-negative and positive gastric cancer via regulatory network analysis
Gastroenterology and Hepatology from Bed to Bench,
Vol. 13 No. 2 (2020),
9 March 2020
,
Page 161-167
https://doi.org/10.22037/ghfbb.v13i2.1906
Abstract
Aim: To understand the molecular difference between H.pylori negative and positive gastric cancer, a regulatory network analysis is investigated.
Background: Helicobacter pylori as the one of the most leading causes of gastric cancer is yet to be studied in terms of its molecular pathogenicity.
Methods: Cytoscape version of 3.7.2 with its applications was employed to conduct this study via corresponding algorithms.
Results: A total of 161 microRNAs were identified differentially expressed in the comparison of two groups of gastric cancer including negative and positive with H.pylori infection. CluePedia explored the regulatory network and found down-regulation dominant while considering the linked hub genes.
Conclusion: It can be concluded that the presented microRNAs and target genes could have associations with H.pylori carcinogenesis in gastric cancer through dysregulation of some vital biological processes. These microRNAs and target genes include hsa-miR-943, hsa-miR-935, hsa-miR-367, hsa-miR-363, hsa-miR-25, and hsa-miR-196b and ADRA1A, KCNA4, SOD1, and SESN3, respectively. However, verification analysis in this regard is required to establish these relationships.
Keywords: Helicobacter pylori, Gastric cancer, MicroRNA, Regulatory network, Hub.
(Please cite as: Abdi S, Zamanian Azodi M, Rezaei-Tavirani M, Razzaghi MR, Heidari MH, Akbarzadeh Baghban AR. Differentiation of H. pylori-negative and positive gastric cancer via regulatory network analysis. Gastroenterol Hepatol Bed Bench 2020;13(2):161-167).
- Helicobacter pylori
- Gastric cancer
- MicroRNA
- Regulatory network
- Hub.
How to Cite
References
Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench 2015;8:S6.
Bernardini G, Figura N, Ponzetto A, Marzocchi B, Santucci A. Application of proteomics to the study of Helicobacter pylori and implications for the clinic. Exp Rev Proteomics 2017;14:477-90.
Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Scientific Rep 2016;6:1-13.
Polk DB, Peek Jr RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010;10:403.
Lin AS, Dooyema SD, Frick-Cheng AE, Harvey ML, Suarez G, Loh JT, et al. Bacterial energetic requirements for Helicobacter pylori Cag Type IV secretion system-dependent alterations in gastric epithelial cells. Infect Immun 2020;88.
Lin LL, Chen CN, Lin WC, Lee PH, Chang KJ, Lai YP, et al. Annexin A4: A novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach. Proteomics Clin Appl 2008;2:619-34.
Ellmark P, Ingvarsson J, Carlsson A, Lundin BS, Wingren C, Borrebaeck CA. Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics 2006;5:1638-46.
Chang H, Kim N, Park JH, Nam RH, Choi YJ, Lee HS, et al. Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection. Gut liver 2015;9:188.
Zhao X, Ren Y, Cui N, Wang X, Cui Y. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis. Medicine 2018;97.
Norouzinia M, Azodi MZ, Seyfi DN, Kardan A, Naseh A, Akbari Z. Predication of hub target genes of differentially expressed microRNAs contributing in Helicobacter Pylori infection in gastric non-cancerous tissue. Gastroenterol Hepatol Bed Bench 2019;12:44-50.
Babicki S, Arndt D, Marcu A, Liang Y, Grant JR, Maciejewski A, et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res 2016;44:W147-53.
Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2010;27:431-2.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504.
Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009;25:1091-3.
Fazeli Z, Alebouyeh M, Tavirani MR, Azimirad M, Yadegar A. Helicobacter pylori CagA induced interleukin-8 secretion in gastric epithelial cells. Gastroenterol Hepatol Bed Bench 2016;9:S42.
Yang J, Song H, Cao K, Song J, Zhou J. Comprehensive analysis of Helicobacter pylori infection-associated diseases based on miRNA-mRNA interaction network. Brief Bioinform 2019;20:1492-501.
Kikuchi T, Itoh F, Toyota M, Suzuki H, Yamamoto H, Fujita M, et al. Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int J Cancer 2002;97:272-7.
Ding S-Z, Fischer W, Kaparakis-Liaskos M, Liechti G, Merrell DS, Grant PA, et al. Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS One 2010; 5:e9875
Zong W-X, Ditsworth D, Bauer DE, Wang Z-Q, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004;18:1272-82.
Grady WM, Ulrich CM. DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas? Gut 2007;56:318-20.
Toller IM, Neelsen KJ, Steger M, Hartung ML, Hottiger MO, Stucki M, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A 2011;108:14944-9.
Arimoto-Kobayashi S, Ohta K, Yuhara Y, Ayabe Y, Negishi T, Okamoto K, et al. Mutagenicity and clastogenicity of extracts of Helicobacter pylori detected by the Ames test and in the micronucleus test using human lymphoblastoid cells. Mutagenesis 2015;30:537-44.
Steinestel K, Wardelmann E, Hartmann W, Grünewald I. Regulators of actin dynamics in gastrointestinal tract tumors. Gastroenterol Res Pract 2015;2015.
Wessler S, Gimona M, Rieder G. Regulation of the actin cytoskeleton in Helicobacter pylori-induced migration and invasive growth of gastric epithelial cells. Cell Commun Signal 2011;9:27.
Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L, et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer 2017;16:76.
Liu J, Wang H, Chen G, Yang M, Wu Z-X, Ericksen RE, et al. The synergy of Helicobacter pyloriand lipid metabolic disorders in induction of Th17-related cytokines in human gastric cancer. J Cancer Metastasis Treat 2017;3:169-76.
- Abstract Viewed: 91 times
- PDF Downloaded: 54 times